Clinical Trials
73 trialsINSPIRE
Singlera Genomics Inc.
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
POSITive
European Institute of Oncology
PITHAC
Centre Hospitalier Universitaire Vaudois
VUBAR
Universitair Ziekenhuis Brussel
The Suitability of Sniff Dog as a Tool in Screening Tumors
Central South University
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
UPLIFT
Massachusetts General Hospital
CAT_PB
Lebanese University
ROME
Fondazione per la Medicina Personalizzata
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
DEFACTO2
Université Sorbonne Paris Nord
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
ELISA
Assistance Publique - Hôpitaux de Paris
CANINE
University of Kansas Medical Center
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)
Second Affiliated Hospital of Soochow University
RESTORE
Blue Note Therapeutics
MICROBIOME
Imperial College London
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
YSCH-01
Shanghai Fengxian District Central Hospital
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
PIONEER
SpeciCare
OMT-111 for Terminal Stage Solid Tumors
MetiMedi Pharmaceuticals
E-SN@P PROJECT
Institut Paoli-Calmettes
DC-CIK
Sun Yat-sen University
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Petra Pharma
Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy
The First Affiliated Hospital of Dalian Medical University
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
The First Affiliated Hospital of Dalian Medical University
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
18F-FSPG PET/CT Imaging in Patients With Cancers
National Taiwan University Hospital
Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion
Peking Union Medical College
CORE
Royal Marsden NHS Foundation Trust
End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer
M.D. Anderson Cancer Center
CONTACT
KU Leuven
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Xuanwu Hospital, Beijing
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.
TR(ACE) Assay Clinical Specimen Study
Biological Dynamics